Published in Biochem Biophys Res Commun on August 13, 1979
Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization. Proc Natl Acad Sci U S A (1987) 0.89
Effect of lipid composition on lipoprotein lipase activity measured by a continuous fluorescence assay: effect of cholesterol supports an interfacial surface penetration model. Biochem J (1997) 0.78
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Human erythrocyte membrane glycoprotein: a re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1971) 5.18
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Am J Clin Nutr (1979) 3.84
Programming the generalization of a greeting response in four retarded children. J Appl Behav Anal (1974) 3.65
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
A comparison of similarity measures for use in 2-D-3-D medical image registration. IEEE Trans Med Imaging (1998) 3.30
Chemical characterization and surface orientation of the major glycoprotein of the human erythrocyte membrane. Proc Natl Acad Sci U S A (1972) 3.27
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
An SNP map of human chromosome 22. Nature (2000) 2.99
Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med (1978) 2.92
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
The medical librarian and computer-assisted instruction. Bull Med Libr Assoc (1974) 2.74
A genetic analysis of neural progenitor differentiation. Neuron (2001) 2.66
1-Palmitoyl-2-pyrenedecanoyl glycerophospholipids as membrane probes: evidence for regular distribution in liquid-crystalline phosphatidylcholine bilayers. Biochemistry (1985) 2.47
Major glycoprotein of the human erythrocyte membrane: evidence for an amphipathic molecular structure. Arch Biochem Biophys (1973) 2.44
Source of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation. Carbohydrate sources, vitamins, and minerals. Am J Clin Nutr (1983) 2.43
Physicochemical properties of rat testis Ca2+-dependent regulator protein of cyclic nucleotide phosphodiesterase. Relationship of Ca2+-binding, conformational changes, and phosphodiesterase activity. J Biol Chem (1977) 2.31
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20
Analysis of monosaccharides by gas-liquid chromatography of the O-methyl glycosides as trifluoroacetate derivatives. Application to glycoproteins and glycolipids. J Chromatogr (1972) 2.19
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04
Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry (1998) 2.00
Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm (2001) 1.98
Sequence homology of the Ca2+-dependent regulator of cyclic nucleotide phosphodiesterase from rat testis with other Ca2+-binding proteins. J Biol Chem (1978) 1.91
Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature (1986) 1.85
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Red cell membrane glycoprotein: amino acid sequence of an intramembranous region. Biochem Biophys Res Commun (1972) 1.80
Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76
Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J (2000) 1.74
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Studies of male survivors of myocardial infarction. XII. Relation of serum lipids and lipoproteins to survival over a 10-year period. Can Med Assoc J (1970) 1.68
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem (1983) 1.67
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Reversibility of the binding of cytochrome c to liposomes. Implications for lipid-protein interactions. J Biol Chem (1995) 1.64
Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Chem Phys Lipids (1997) 1.64
Sequence requirements for plasmid nuclear import. Exp Cell Res (1999) 1.63
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother (1999) 1.63
Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res (1995) 1.62
Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation. Genetics (1997) 1.62
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med (1978) 1.59
Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla. Hear Res (2000) 1.58
The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim Biophys Acta (1972) 1.57
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
A biological environmental chamber for the culture of Neisseria gonorrhoeae. J Am Vener Dis Assoc (1975) 1.57
Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.54
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem (1986) 1.50
The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Circulation (1986) 1.50
Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos. Genetics (1998) 1.47
Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med (1989) 1.46
The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis (1982) 1.45
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr (1985) 1.45
The primary structure of porcine pancreatic ribonuclease. I. The distribution and sites of carbohydrate attachment. J Biol Chem (1970) 1.45
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb (1993) 1.45
Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins. J Biol Chem (1984) 1.44
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
Risk reduction. Circulation (2000) 1.42
Communication patterns in a biomedical research center. J Med Educ (1978) 1.42
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med (Berl) (2000) 1.42
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol (1991) 1.42
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry (1978) 1.41
Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study. Blood Purif (2006) 1.40
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun (1978) 1.39
Bayesian analysis of pentaquark signals from CLAS data. Phys Rev Lett (2008) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med (1978) 1.38